4//SEC Filing
Caissa Capital Management ltd. 4
Accession 0001929354-23-000010
CIK 0001534120other
Filed
May 23, 8:00 PM ET
Accepted
May 24, 4:15 PM ET
Size
8.0 KB
Accession
0001929354-23-000010
Insider Transaction Report
Form 4
Caissa Capital Management ltd.
10% Owner
Transactions
- Purchase
Common Stock
2023-05-24$2.96/sh+5,519$16,348→ 1,382,700 total(indirect: See Footnote (1)) - Purchase
Common Stock
2023-05-24$3.01/sh+3,481$10,468→ 1,377,181 total(indirect: See Footnote (1))
Holdings
- 182,300
Common Stock
Footnotes (4)
- [F1]Shares held by Caissa Capital Management Ltd, a British Virgin Islands company controlled by Mr. Golestaneh.
- [F2]The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $3.0 to $3.01, inclusive.
- [F3]The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $2.92 to $3.03, inclusive.
- [F4]These shares are directly owned by Mr. Golestaneh in his personal capacity.
Documents
Issuer
Avalo Therapeutics, Inc.
CIK 0001534120
Entity typeother
IncorporatedVirgin Islands, British
Related Parties
1- filerCIK 0001929354
Filing Metadata
- Form type
- 4
- Filed
- May 23, 8:00 PM ET
- Accepted
- May 24, 4:15 PM ET
- Size
- 8.0 KB